ORANGE | CIK:0001038143 | 3

  • Filed: 4/24/2018
  • Entity registrant name: ORANGE (CIK: 0001038143)
  • Generator: Merrill
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1038143/000110465918025968/0001104659-18-025968-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1038143/000110465918025968/oran-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001038143
  • Open this page in separate window: Click
  • ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory

    Assets available for sale

    The Group’s assets available for sale mainly consist of investment securities, which are not consolidated and not accounted for using the equity method, and marketable securities that do not fulfill the criteria for classification in any of the other categories of financial assets. They are recognized at fair value at inception and subsequently.

    Temporary changes in value are recorded as “Gains (losses) on assets available for sale” within other comprehensive income.

    When there is an objective evidence of impairment on available-for-sale assets or a decrease in fair value by at least one-third or over 2 consecutive semesters, the cumulative impairment loss included in other comprehensive income is definitely reclassified from equity to profit or loss within net financial expenses.

    Financial assets at fair value through profit or loss

    The Group can designate at fair value at inception financial investments such as negotiable debt securities, deposits and mutual funds (UCITS), that are compliant with the Group’s risk management policy or investment strategy (see Note 12.3). They are recognized at fair value at inception and subsequently. All changes in fair value are recorded in net financial expenses.

    Other financial assets

    This category mainly includes loans and receivables. These instruments are recognized at fair value at inception and are subsequently measured at amortized cost using the effective interest method. If there is any objective evidence of impairment of these assets, the value of the asset is reviewed at the end of each reporting period. An impairment loss is recognized in the income statement when impairment tests demonstrate that the financial asset carrying amount is higher than its recoverable amount.